You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Blood Sugar Articles
Popular Blood Sugar Articles
Highly Recommended Blood Sugar Articles
Send a link to this page to your friends and colleagues.
Although spending on diabetes medications increased substantially, use of the drugs increased by only 2.3 percent in 2007. The discrepancy is explained by the fact that the cost of diabetes treatments rose sharply as patients shifted to newer drugs.
Diabetes treatments are now the leading driver of prescription drug spending growth, displacing lipid-lowering drugs, which tumbled in price after a reign of 10 years in the top position. Generic drugs are cutting the cost of treating high cholesterol.
That’s the conclusion of Medco Health Solutions, Inc., a pharmacy benefit management company, in its just released “2008 Drug Trend Report,” a comprehensive analysis of prescription drug spending and utilization.
The report shows that despite continued growth in the use of cholesterol drugs, spending fell 8.5 percent in 2007 as usage of lower-cost generic versions of Pravachol and Zocor expanded in the marketplace. As a result, lipid-lowering medications experienced the greatest spending decline of all drug categories.
Meanwhile, spending on diabetes drugs increased 12 percent due to shifts toward higher-cost treatments, brand-name drug price inflation, and moderate growth in the number of patients receiving treatment.
A Move to Newer Diabetes Drugs
Although spending on diabetes medications increased substantially, use of the drugs increased by only 2.3 percent in 2007. The discrepancy is explained by the fact that the cost of diabetes treatments rose sharply as patients shifted to newer drugs. These recently introduced medications have advantages over older drugs because they are faster-acting and help patients better maintain consistent blood sugar levels to prevent complications.
A sharp drop in Avandia use due to safety concerns, the withdrawal from the market of an inhalable form of insulin, and declining unit costs for many generic versions of diabetes drugs were not enough to offset the trend toward higher-cost treatments.
“The diabetes epidemic and the introduction of new products are reshaping prescription spending patterns,” says Medco Chief Medical Officer Robert S. Epstein, MD. “The number of people diagnosed with diabetes is increasing by about a million patients per year, meaning more people need complex drug therapies to control their blood sugar.”
Two- or three-drug combinations are frequently being used to reduce the complications associated with diabetes, which affects about 21 million Americans. However, only 7 percent of patients with the disorder achieve target goals for blood glucose, cholesterol and blood pressure.
For a decade, cholesterol drugs were the largest driver of “drug trend” –a measure of spending growth for pharmacy benefit plans. These medications still account for a sizable 10.8 percent of all prescription costs, with utilization rising 5.9 percent last year as new clinical guidelines expanded the population that can benefit from these treatments.
Categories: Blood Glucose, Blood Sugar, Diabetes, Diabetes, Insulin, Pharmacy
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Is this a good position to be in?
If more people tried eating the right food, and exercise to lose weight, they would be able to skip the cholesterol-lowering drugs. My husband did it easily, and he's glad that his cholesterol levels are now within the norm without drugs. They (and the LDL and HDL ratio) have been excellent for many years now.
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...